دورية أكاديمية

97P Efficacy and safety of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer: Long-term data from the PHranceSCa study

التفاصيل البيبلوغرافية
العنوان: 97P Efficacy and safety of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer: Long-term data from the PHranceSCa study
المؤلفون: O'Shaughnessy, J., Sousa, S.P., Jurado, J. Cruz, Fallowfield, L.J., Auvinen, P., Pulido, C., Cvetanovic, A.S., Wilks, S.T., Ribeiro, L.A., Burotto, M., Boulet, T., Revelant, V., Theron, N., Trask, P., Wahyudi, L.A., Machackova, Z., Stamatovic, L.
المصدر: In ESMO Open May 2023 8(1) Supplement 4
قاعدة البيانات: ScienceDirect
الوصف
تدمد:20597029
DOI:10.1016/j.esmoop.2023.101321